Research has also noted a relationship between methylation patterns at CpG sites targeting SMOC1, KCNA4, SLC25A21, and UPP1, and the molecular characteristics of glioma, such as IDH mutations and 1p/19q co‐deletions, which aligns with our findings [16]. The gene discussed is IDH1; the disease is glioma.